Cargando…

In Vitro Activity of 22 Antibiotics against Achromobacter Isolates from People with Cystic Fibrosis. Are There New Therapeutic Options?

Bacteria belonging to the genus Achromobacter are increasingly isolated from respiratory samples of people with cystic fibrosis (PWCF). The management of this multidrug-resistant genus is challenging and characterised by a lack of international recommendations, therapeutic guidelines and data concer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beauruelle, Clémence, Lamoureux, Claudie, Mashi, Arsid, Ramel, Sophie, Le Bihan, Jean, Ropars, Thomas, Dirou, Anne, Banerjee, Anandadev, Tandé, Didier, Le Bars, Hervé, Héry-Arnaud, Geneviève
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703882/ https://www.ncbi.nlm.nih.gov/pubmed/34946075 http://dx.doi.org/10.3390/microorganisms9122473

Ejemplares similares

An observational study of anaerobic bacteria in cystic fibrosis lung using culture dependant and independent approaches
por: Lamoureux, Claudie, et al.
Publicado: (2021)

Prevotella melaninogenica, a Sentinel Species of Antibiotic Resistance in Cystic Fibrosis Respiratory Niche?
por: Lamoureux, Claudie, et al.
Publicado: (2021)

The Human Microbiome, an Emerging Key-Player in the Sex Gap in Respiratory Diseases
por: Beauruelle, Clémence, et al.
Publicado: (2021)

Evaluation of the Performance Characteristics of a New POC Multiplex PCR Assay for the Diagnosis of Viral and Bacterial Neuromeningeal Infections
por: Le Bars, Hervé, et al.
Publicado: (2023)

Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome
por: Pailhoriès, Hélène, et al.
Publicado: (2022)

Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis
por: Le Goff, Mélanie, et al.
Publicado: (2022)

Achromobacter spp. genetic adaptation in cystic fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
por: Chalhoub, Hussein, et al.
Publicado: (2022)

The Microbiome in Cystic Fibrosis Pulmonary Disease
por: Françoise, Alice, et al.
Publicado: (2020)

Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis
por: Tetart, Macha, et al.
Publicado: (2019)

Sputum versus nasopharyngeal samples for the molecular diagnosis of respiratory viral infection in cystic fibrosis: A pilot study
por: Cardot-Martin, Emilie, et al.
Publicado: (2021)

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
por: Lambiase, A., et al.
Publicado: (2011)

VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France
por: Neuwirth, Catherine, et al.
Publicado: (2006)

Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
por: Firmida, M.C., et al.
Publicado: (2016)

Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection
por: Veschetti, Laura, et al.
Publicado: (2020)

Genetic Adaptation of Achromobacter sp. during Persistence in the Lungs of Cystic Fibrosis Patients
por: Ridderberg, Winnie, et al.
Publicado: (2015)

Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports
por: Firmida, Mônica Cássia, et al.
Publicado: (2017)

Achromobacter spp. Adaptation in Cystic Fibrosis Infection and Candidate Biomarkers of Antimicrobial Resistance
por: Sandri, Angela, et al.
Publicado: (2022)

2275. Novel Therapeutic Options for the Treatment of Multi-Drug-Resistant Achromobacter Respiratory Infections
por: Canonica, Theora, et al.
Publicado: (2019)

Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease
por: Stobbelaar, Kim, et al.
Publicado: (2016)

Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature
por: Cools, Piet, et al.
Publicado: (2016)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

Complete Genome Sequence of Achromobacter xylosoxidans Myophage Mano
por: Bartz, Mariah, et al.
Publicado: (2021)

Compounding Achromobacter Phages for Therapeutic Applications
por: Cobián Güemes, Ana Georgina, et al.
Publicado: (2023)

Draft Genome Sequence of Triclosan-Resistant Cystic Fibrosis Isolate Achromobacter xylosoxidans CF304
por: Jeukens, Julie, et al.
Publicado: (2015)

Complete Genome Sequence of Achromobacter xylosoxidans MN001, a Cystic Fibrosis Airway Isolate
por: Badalamenti, Jonathan P., et al.
Publicado: (2015)

Draft genome sequences of four Achromobacter ruhlandii strains isolated from cystic fibrosis patients
por: Rodrigues, Elenice RA, et al.
Publicado: (2016)

Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes
por: Nielsen, Signe M., et al.
Publicado: (2016)

730. Cefiderocol for the Treatment of Achromobacter xylosoxidans Infections in Two Lung Transplant Patients with Cystic Fibrosis
por: Warner, Nathaniel C, et al.
Publicado: (2019)

Adaptive Interactions of Achromobacter spp. with Pseudomonas aeruginosa in Cystic Fibrosis Chronic Lung Co-Infection
por: Sandri, Angela, et al.
Publicado: (2021)

Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic Fibrosis
por: Khademi, S. M. Hossein, et al.
Publicado: (2021)

Exoproducts of the Most Common Achromobacter Species in Cystic Fibrosis Evoke Similar Inflammatory Responses In Vitro
por: Sahl, Cecilia, et al.
Publicado: (2023)

Duplex real-time PCR assay for the simultaneous detection of Achromobacter xylosoxidans and Achromobacter spp.
por: Price, Erin P., et al.
Publicado: (2020)

Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis
por: Le Gall, Florence, et al.
Publicado: (2013)

Osteomyelitis caused by Achromobacter xylosoxidans
por: Shinha, Takashi, et al.
Publicado: (2015)

Bacteraemia by Achromobacter denitrificans in Hemodialysis
por: Chávez-Valencia, Venice, et al.
Publicado: (2021)

Mobilome Analysis of Achromobacter spp. Isolates from Chronic and Occasional Lung Infection in Cystic Fibrosis Patients
por: Veschetti, Laura, et al.
Publicado: (2021)

Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients
por: Veschetti, Laura, et al.
Publicado: (2021)

Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients’ Lung
por: Menetrey, Quentin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p2mdf9hcill46l5d8ene657ntg